Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital

BACKGROUND AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome virus, which has affected billions of people across the globe. The pathogenesis of respiratory inflammation involves elevated concentration of interleukin-6; he...

Descripción completa

Detalles Bibliográficos
Autores principales: Shastri, Minal, Raval, Darshankumar Manubhai, Bharmal, Ummayhany Fakhruddin, Rathod, Vaishnavi M, Desai, Bhavi, Shah, Priyansh V., Jain, Mohak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746268/
https://www.ncbi.nlm.nih.gov/pubmed/36629229
http://dx.doi.org/10.4103/lungindia.lungindia_349_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746268/
https://www.ncbi.nlm.nih.gov/pubmed/36629229
http://dx.doi.org/10.4103/lungindia.lungindia_349_22

Ejemplares similares